Gene-edited kidney transplant to lower rejection risk
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a specially edited donor kidney designed to reduce the chance of rejection, especially for people with high sensitivity to donor kidneys. If it works, it could make more kidneys available for those who have a hard time finding a match.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have end-stage kidney disease and are on the waiting list for a kidney transplant.
- You are between 16 and 85 years old.
- A suitable donor kidney (matching your blood type) is available for the study.
- You are willing to travel to the study center in China for long-term follow-up.
- You are not pregnant or breastfeeding, and agree to use effective birth control.
- You do not have an active infection or other serious health condition that would make transplant unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special immune cell treatment (CAR-T cells) can lower the antibodies that make it very hard for you to receive a kidney transplant. If it works, you might become eligible for a transplant sooner.
This study looks at the genes of people who have had or will have a kidney transplant. It aims to learn how genetic information might help improve transplant care over time. Participants will give blood, urine, stool, and possibly kidney tissue samples for research.
This study tests whether giving a special mix of donor immune cells along with immune-suppressing medicines right after a kidney transplant can help the body accept the new kidney without long-term anti-rejection drugs. It aims to reduce the need for daily transplant medications.
This early-phase trial tests a new therapy that uses your own immune cells to reduce your body's attack on a new kidney. It aims to help people who are highly sensitized (hard to match) get a transplant successfully.
This trial tests a liver transplant using a donor organ that has been gene-edited to reduce the risk of rejection. It may help people who need a liver transplant and are not a perfect tissue match with their donor.
This study looks at how genes in the kidney change when the body might be rejecting the transplant. By studying these genes, doctors hope to find better ways to detect kidney rejection early and help keep the kidney healthy longer.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.